Louis Navellier and the InvestorPlace Research Staff, Author at Daily Trade Alert

7 Top-Rated Pharma Stocks to Buy in July

These stocks have inherent risk… but their long-term growth potential is considerable.

The company is ideally positioned to keep winning on multiple fronts.

Each has an ‘A’ rating in my Portfolio Grader.

Virtually everything that isn’t already connected will be, and these names look pretty tempting right now.

Traders can take advantage of its very reasonable price… which might not stay low for much longer.